Which prostate radiation is easier on patients? new trial aims to find out

NCT ID NCT03426748

Ongoing Disease control Sponsor: British Columbia Cancer Agency Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two radiation methods for men with low- or intermediate-risk prostate cancer: low dose rate (permanent seed implants) and high dose rate (temporary radioactive needles). The main goal is to see which approach better preserves urinary quality of life. About 140 men will be followed for up to 5 years to track side effects and recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiation therapy (low dose rate or high dose rate brachytherapy)
What this could lead to: If this trial succeeds, it could show which brachytherapy method causes fewer urinary side effects while controlling prostate cancer equally well.
What could go wrong: This is an early-stage comparison with 140 participants, so results may not apply to all patients. Both treatments involve radiation risks like urinary or bowel problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

British Columbia Cancer Agency Center for the Southern Interior

Kelowna, British Columbia, V1Y5L3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.